Integration of bulk and single-cell transcriptomic sequencing reveals the neutrophil heterogeneity in bladder cancer and establishes a prognostic model

整合批量和单细胞转录组测序数据揭示了膀胱癌中性粒细胞的异质性,并建立了预后模型

阅读:6

Abstract

Neutrophils are crucial immune components within the tumor microenvironment, significantly impacting tumor progression and anti-tumor immunity. To systematically characterize the heterogeneity of neutrophils in bladder cancer (BLCA), we integrated large-scale single-cell RNA sequencing (scRNA-seq) data of BLCA to define the transcriptomic landscape of neutrophil subtypes. Functional enrichment, pseudotime analysis, cell-cell communication, and deconvolution of bulk RNA sequencing (RNA-seq) samples from BLCA were conducted to comprehensively characterize the biological profiles and functions, as well as the prognostic relevance of neutrophil subtypes. A machine learning-based predictive model was developed based on the balance of prognosis-related neutrophil subtypes. We identified five distinct subtypes of neutrophils in BLCA and focused on two subtypes that were prognostically antagonistic. VEGFA+ neutrophils (Neu_0), characterized by pro-angiogenic, immunosuppressive, and extracellular matrix remodeling signatures, showed a significant correlation with poorer survival. GBP1 + neutrophils (Neu_4), characterized by response to interferon, exhibited increased innate immune activities and the production of cytokines that activate anti-tumor immunity, significantly correlated with improved survival. Pseudotime analysis positioned both Neu_0 and Neu_4 as terminal states. Cell-cell communication further identified Neu_0 as a hub orchestrating multiple pro-tumorigenic interactions. The predictive model based on the balance of Neu_0 and Neu_4 effectively stratified BLCA patients into distinct risk groups with significant differences in clinical outcomes, immune landscapes, and response profiles to antibody-drug conjugate (ADC) treatment. The investigation provided novel insights into the functional profiles of neutrophils in BLCA and offered a novel tool for guiding therapeutic strategies in BLCA. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12672-026-04559-3.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。